Intong, Baby Boy .

HRN: 25-08-35  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/26/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
06/26/2024
07/02/2024
IV
30mg
OD
Potentially Septic Newborn
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Unspecified Sepsis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: